Oligoastrocytoma pathophysiology: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Oligoastrocytoma}} {{CMG}}{{AE}}{{SR}} ==Overview== ==Pathophysiology== ===Pathogenesis=== ===Genetics=== *Genes associated with the pathogenesis of oligoastroc...") |
|||
| Line 29: | Line 29: | ||
===Immunohistochemistry=== | ===Immunohistochemistry=== | ||
Oligoastrocytoma is demonstrated by positivity to tumor markers such as: | Oligoastrocytoma is demonstrated by positivity to tumor markers such as: | ||
*[[MAP2]] | |||
*[[GFAP]] | |||
==References== | ==References== | ||
Revision as of 14:15, 16 October 2015
|
Oligoastrocytoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Oligoastrocytoma pathophysiology On the Web |
|
American Roentgen Ray Society Images of Oligoastrocytoma pathophysiology |
|
Risk calculators and risk factors for Oligoastrocytoma pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
Pathophysiology
Pathogenesis
Genetics
- Genes associated with the pathogenesis of oligoastrocytoma include:
Gross Pathology
- On gross pathology, oligoastrocytoma is characterized by
Gallery
Microscopic Pathology
On microscopic histopathological analysis, oligoastrocytoma is characterized by:
On microscopic histopathological analysis, anaplastic oligoastrocytoma is characterized by:
Gallery
Immunohistochemistry
Oligoastrocytoma is demonstrated by positivity to tumor markers such as: